As mentioned, Versacloz belongs to a group of medicines known as atypical antipsychotics (also called second-generation antipsychotics). It is thought to work by blocking the action of dopamine, a neurotransmitter chemical in the brain that is believed to be elevated in people with schizophrenia.
Like other atypical antipsychotics, Versacloz also blocks a type of serotonin receptor. Serotonin is another brain chemical, and blocking this receptor is thought to help control some of the symptoms of schizophrenia.
Versacloz is not approved for use in children (usually defined as individuals younger than age 18), as it has not been adequately studied in this age group. Talk with your child's healthcare provider about the particular benefits and risks of using this medicine in children.
Older adults may be more sensitive to certain Versacloz side effects, including movement disorders, constipation, and urinary retention (difficulty urinating). In general, older adults should be treated cautiously, as they may need to be closely monitored or need lower-than-usual doses.